Resmed (RSMDF) Other Non Operating Income (2009 - 2026)
Resmed's (RSMDF) quarterly Other Non Operating Income came in at $1.3 million in Q2 2026, up 236.26% on a YoY basis from $396715.1 in Q2 2025, and up 197.16% quarter-over-quarter from -$1.4 million in Q1 2026.
Analysis
Resmed (RSMDF) Other Non Operating Income (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Other Non Operating Income for 18 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 236.26% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at -$9.2 million (down 74.22% YoY), and the FY2026 full-year result was -$9.2 million, down 74.16% from the prior year.
- Other Non Operating Income advanced to $1.3 million in Q2 2026 per RSMDF's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.6 million in Q3 2023 and bottomed at -$5.3 million in Q4 2025.
- Historically, Other Non Operating Income has averaged -$1.1 million across 5 years, with a median of -$1.4 million in 2022.
- The widest YoY moves for Other Non Operating Income: up 423.03% in 2024, down 4947.54% in 2024.
- Over 5 years, Other Non Operating Income stood at -$1.7 million in 2022, then soared by 59.81% to -$686000.0 in 2023, then surged by 423.03% to $2.2 million in 2024, then slumped by 338.36% to -$5.3 million in 2025, then surged by 125.26% to $1.3 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.3 million, -$1.4 million, and -$5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | -1.37 Mn |
| Dec 31, 2025 | -5.28 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | -979,000.00 |
| Mar 31, 2025 | -4.06 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.50 Mn |
| Dec 31, 2023 | -686,000.00 |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | -2.56 Mn |
| Dec 31, 2022 | -1.71 Mn |
| Sep 30, 2022 | -1.50 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 841,000.00 |
| Sep 30, 2021 | -1.99 Mn |